Antibodies Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

  • Published : Aug-2017
  • Tables : 271
  • Figures : 99
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT194MR
  • Format : ppt

The global demand for antibodies is expected to remain moderate in the forthcoming years. Increasing prevalence of chronic ailments such as autoimmune diseases, cancer, diabetes and others is encouraging manufacturers to step up investments in R&D activities pertaining to antibodies. In addition, frequent outbreak of infectious diseases in various parts of the world coupled with growing popularity of protein therapeutics, is driving the sales of antibodies drugs. Sales of antibody-based medicines is expected to remain steady in developed regions such as Europe and North America. At the same time, introduction of alternative therapeutic drugs is projected to impact the growth of the global antibodies market. Moreover, factors such as risk of side effects related with antibodies and high-cost remain the major growth deterrents of the market. According to the latest report published by Fact.MR, the global antibodies market is expected to surpass a valuation of US$ 3,000 Mn by end of 2022, reflecting a steady CAGR between 2017 and 2022.

Antibodies (Ab) are also known as immunoglobulin (Ig). These are the large, Y-shaped protein that are produced primarily by plasma cells present in the blood in response to pathogens such as viruses and bacteria. Antibodies are capable of identifying unique molecules with harmful agents. Antibodies are used in various therapeutic areas as well as in diagnostics of disease indications such as rheumatoid arthritis, non-Hodgkin lymphoma, psoriasis, macular degeneration, asthma, Crohn’s disease, and hypercholesterolemia.

Market Taxonomy

Product Type

End User

Application

Immune Checkpoint Antibodies

Biopharmaceutical Companies

Drug Discovery & Development

Epitope Tag Antibodies

Contract Research Organizations (CROs)

Basic Research

Isotype Control Antibodies

Academic & Research Institutes

Toxicity Screening

Primary Antibodies

Forensic Science Laboratories

Biopharmaceutical Production

Assay Antibodies (includes secondary antibodies)

Food & Beverage Companies

Drug Screening

Other

Diagnostic Centers

Tissue Engineering

 

Others

Forensic Testing

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

North America at the Forefront of the Global Antibodies Market

Currently, North America dominates the global antibodies market in terms of revenue and trend is projected continue in 2017 and beyond. In addition, the market in the region is expected to increase at a moderate CAGR during the forecast period (2017-2022). Presence of leading market players and existence of a well-established healthcare infrastructure is supporting the growth of the market in the region.

Primary Antibodies to Remain Top Selling Product Type  

On the basis of product type, the primary antibodies segment currently accounts for the highest share of the global antibodies market in terms of revenue. Towards the end of forecast period, the segment is expected to reach a valuation in excess of US$ 1,091 Mn, reflecting a steady CAGR. The primary antibodies segment is projected to create an absolute $ opportunity of US$ 168.4 Mn between 2017 and 2022.

Competition Tracking

The report has also profiled key players operating in the global antibodies market, which include Abcam Plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Genscript Biotech Corporation, Sigma Aldrich Corp, Crown Bioscience, Inc., Thermo Fisher Scientific, Inc.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

1. Global Antibodies Market - Executive Summary

2. Global Antibodies Market Overview
2.1. Introduction
       2.1.1. Global Antibodies Market Taxonomy
       2.1.2. Global Antibodies Market Definition
2.2. Global Antibodies Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Antibodies Market Y-o-Y Growth
2.3. Global Antibodies Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis 
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Antibodies Market Analysis and Forecast By Product Type 
3.1. Global Antibodies Market Size and Forecast By Product Type, 2012-2022
       3.1.1. Immune Checkpoint Antibodies Antibodies Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Epitope Tag Antibodies Antibodies Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region
        3.1.3. Isotype Control Antibodies Antibodies Market Size and Forecast, 2012-2022
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region
                3.1.3.2. Market Share Comparison, By Region
                3.1.3.3. Y-o-Y growth Comparison, By Region
       3.1.4. Primary Antibodies Antibodies Market Size and Forecast, 2012-2022
                3.1.4.1. Revenue (US$ Mn) Comparison, By Region
                3.1.4.2. Market Share Comparison, By Region
                3.1.4.3. Y-o-Y growth Comparison, By Region
       3.1.5. Assay Antibodies (includes secondary antibodies) Antibodies Market Size and Forecast, 2012-2022
                3.1.5.1. Revenue (US$ Mn) Comparison, By Region
                3.1.5.2. Market Share Comparison, By Region
                3.1.5.3. Y-o-Y growth Comparison, By Region
       3.1.6. Other  Antibodies Market Size and Forecast, 2012-2022
                3.1.6.1. Revenue (US$ Mn) Comparison, By Region
                3.1.6.2. Market Share Comparison, By Region
                3.1.6.3. Y-o-Y growth Comparison, By Region

4. Global Antibodies Market Analysis and Forecast By End User 
4.1. Global Antibodies Market Size and Forecast By End User, 2012-2022
       4.1.1. Biopharmaceutical Companies Antibodies Market Size and Forecast, 2012-2022
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Contract Research Organizations (CROs) Antibodies Market Size and Forecast, 2012-2022
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Academic & Research Institutes Antibodies Market Size and Forecast, 2012-2022
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
       4.1.4. Forensic Science Laboratories Antibodies Market Size and Forecast, 2012-2022
                4.1.4.1. Revenue (US$ Mn) Comparison, By Region
                4.1.4.2. Market Share Comparison, By Region
                4.1.4.3. Y-o-Y growth Comparison, By Region
       4.1.5. Food & Beverage Companies Antibodies Market Size and Forecast, 2012-2022
                4.1.5.1. Revenue (US$ Mn) Comparison, By Region
                4.1.5.2. Market Share Comparison, By Region
                4.1.5.3. Y-o-Y growth Comparison, By Region
       4.1.6. Diagnostic Centers Antibodies Market Size and Forecast, 2012-2022
                4.1.6.1. Revenue (US$ Mn) Comparison, By Region
                4.1.6.2. Market Share Comparison, By Region
                4.1.6.3. Y-o-Y growth Comparison, By Region
       4.1.7. Others Antibodies Market Size and Forecast, 2012-2022
                4.1.7.1. Revenue (US$ Mn) Comparison, By Region
                4.1.7.2. Market Share Comparison, By Region
                4.1.7.3. Y-o-Y growth Comparison, By Region

5. Global Antibodies Market Analysis and Forecast By Application 
5.1. Global Antibodies Market Size and Forecast By Application, 2012-2022
       5.1.1. Drug Discovery & Development Antibodies Market Size and Forecast, 2012-2022
                5.1.1.1. Revenue (US$ Mn) Comparison, By Region
                5.1.1.2. Market Share Comparison, By Region
                5.1.1.3. Y-o-Y growth Comparison, By Region
       5.1.2. Basic Research Antibodies Market Size and Forecast, 2012-2022
                5.1.2.1. Revenue (US$ Mn) Comparison, By Region
                5.1.2.2. Market Share Comparison, By Region
                5.1.2.3. Y-o-Y growth Comparison, By Region
       5.1.3. Toxicity Screening Antibodies Market Size and Forecast, 2012-2022
                5.1.3.1. Revenue (US$ Mn) Comparison, By Region
                5.1.3.2. Market Share Comparison, By Region
                5.1.3.3. Y-o-Y growth Comparison, By Region
       5.1.4. Biopharmaceutical Production Antibodies Market Size and Forecast, 2012-2022
                5.1.4.1. Revenue (US$ Mn) Comparison, By Region
                5.1.4.2. Market Share Comparison, By Region
                5.1.4.3. Y-o-Y growth Comparison, By Region
       5.1.5. Drug Screening Antibodies Market Size and Forecast, 2012-2022
                5.1.5.1. Revenue (US$ Mn) Comparison, By Region
                5.1.5.2. Market Share Comparison, By Region
                5.1.5.3. Y-o-Y growth Comparison, By Region
       5.1.6. Tissue Engineering Antibodies Market Size and Forecast, 2012-2022
                5.1.6.1. Revenue (US$ Mn) Comparison, By Region
                5.1.6.2. Market Share Comparison, By Region
                5.1.6.3. Y-o-Y growth Comparison, By Region
       5.1.7. Forensic Testing Antibodies Market Size and Forecast, 2012-2022
                5.1.7.1. Revenue (US$ Mn) Comparison, By Region
                5.1.7.2. Market Share Comparison, By Region
                5.1.7.3. Y-o-Y growth Comparison, By Region

6. Global Antibodies Market Analysis and Forecast By Region
6.1. Global Antibodies Market Size and Forecast, 2012-2022
       6.1.1. North America Antibodies Market Size and Forecast, 2012-2022
                6.1.1.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.1.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.1.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.2. Latin America Antibodies Market Size and Forecast, 2012-2022
                6.1.2.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.2.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.2.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.3. Europe Antibodies Market Size and Forecast, 2012-2022
                6.1.3.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.3.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.3.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.4. Japan Antibodies Market Size and Forecast, 2012-2022
                6.1.4.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.4.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.4.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.5. APEJ Antibodies Market Size and Forecast, 2012-2022
                6.1.5.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.5.2. Revenue (US$ Mn) Comparison, By End User 
                 6.1.5.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.6. MEA Antibodies Market Size and Forecast, 2012-2022
                6.1.6.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.6.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.6.3. Revenue (US$ Mn) Comparison, By Application 

7. North America Antibodies Market Analysis and Forecast, By Country, 2012-2022
7.1. US Antibodies Market Size and Forecast, 2012-2022
       7.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       7.1.2. Revenue (US$ Mn) Comparison, By End User 
       7.1.3. Revenue (US$ Mn) Comparison, By Application 
7.2. Canada Antibodies Market Size and Forecast, 2012-2022
       7.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       7.2.2. Revenue (US$ Mn) Comparison, By End User 
       7.2.3. Revenue (US$ Mn) Comparison, By Application 

8. Latin America Antibodies Market Analysis and Forecast, By Country, 2012-2022
8.1. Brazil Antibodies Market Size and Forecast, 2012-2022
       8.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       8.1.2. Revenue (US$ Mn) Comparison, By End User 
       8.1.3. Revenue (US$ Mn) Comparison, By Application 
8.2. Mexico Antibodies Market Size and Forecast, 2012-2022
       8.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       8.2.2. Revenue (US$ Mn) Comparison, By End User 
       8.2.3. Revenue (US$ Mn) Comparison, By Application 
8.3. Argentina Antibodies Market Size and Forecast, 2012-2022
       8.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       8.3.2. Revenue (US$ Mn) Comparison, By End User 
       8.3.3. Revenue (US$ Mn) Comparison, By Application 

9. Europe Antibodies Market Analysis and Forecast, By Country, 2012-2022
9.1. Germany Antibodies Market Size and Forecast, 2012-2022
       9.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.1.2. Revenue (US$ Mn) Comparison, By End User 
       9.1.3. Revenue (US$ Mn) Comparison, By Application 
9.2. UK Antibodies Market Size and Forecast, 2012-2022
       9.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.2.2. Revenue (US$ Mn) Comparison, By End User 
       9.2.3. Revenue (US$ Mn) Comparison, By Application 
9.3. France Antibodies Market Size and Forecast, 2012-2022
       9.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.3.2. Revenue (US$ Mn) Comparison, By End User 
       9.3.3. Revenue (US$ Mn) Comparison, By Application 
9.4. Spain Antibodies Market Size and Forecast, 2012-2022
       9.4.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.4.2. Revenue (US$ Mn) Comparison, By End User 
       9.4.3. Revenue (US$ Mn) Comparison, By Application 
9.5. Italy Antibodies Market Size and Forecast, 2012-2022
       9.5.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.5.2. Revenue (US$ Mn) Comparison, By End User 
       9.5.3. Revenue (US$ Mn) Comparison, By Application 
9.6. Nordic Antibodies Market Size and Forecast, 2012-2022
       9.6.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.6.2. Revenue (US$ Mn) Comparison, By End User 
       9.6.3. Revenue (US$ Mn) Comparison, By Application 

10. Japan Antibodies Market Analysis and Forecast, By Country, 2012-2022
10.1. Japan  Antibodies Market Size and Forecast, 2012-2022
       10.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       10.1.2. Revenue (US$ Mn) Comparison, By End User 
       10.1.3. Revenue (US$ Mn) Comparison, By Application 

11. APEJ Antibodies Market Analysis and Forecast, By Country, 2012-2022
11.1. China Antibodies Market Size and Forecast, 2012-2022
       11.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.1.2. Revenue (US$ Mn) Comparison, By End User 
       11.1.3. Revenue (US$ Mn) Comparison, By Application 
11.2. India Antibodies Market Size and Forecast, 2012-2022
       11.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.2.2. Revenue (US$ Mn) Comparison, By End User 
       11.2.3. Revenue (US$ Mn) Comparison, By Application 
11.3. Malaysia Antibodies Market Size and Forecast, 2012-2022
       11.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.3.2. Revenue (US$ Mn) Comparison, By End User 
       11.3.3. Revenue (US$ Mn) Comparison, By Application 
11.4. Thailand Antibodies Market Size and Forecast, 2012-2022
       11.4.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.4.2. Revenue (US$ Mn) Comparison, By End User 
       11.4.3. Revenue (US$ Mn) Comparison, By Application 
11.5. Singapore Antibodies Market Size and Forecast, 2012-2022
       11.5.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.5.2. Revenue (US$ Mn) Comparison, By End User 
       11.5.3. Revenue (US$ Mn) Comparison, By Application 
11.6. Australia Antibodies Market Size and Forecast, 2012-2022
       11.6.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.6.2. Revenue (US$ Mn) Comparison, By End User 
       11.6.3. Revenue (US$ Mn) Comparison, By Application 

12. MEA Antibodies Market Analysis and Forecast, By Country, 2012-2022
12.1. GCC Countries Antibodies Market Size and Forecast, 2012-2022
       12.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.1.2. Revenue (US$ Mn) Comparison, By End User 
       12.1.3. Revenue (US$ Mn) Comparison, By Application 
12.2. South Africa Antibodies Market Size and Forecast, 2012-2022
       12.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.2.2. Revenue (US$ Mn) Comparison, By End User 
       12.2.3. Revenue (US$ Mn) Comparison, By Application 
12.3. Nigeria Antibodies Market Size and Forecast, 2012-2022
       12.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.3.2. Revenue (US$ Mn) Comparison, By End User 
       12.3.3. Revenue (US$ Mn) Comparison, By Application 
12.4. Israel Antibodies Market Size and Forecast, 2012-2022
       12.4.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.4.2. Revenue (US$ Mn) Comparison, By End User 
       12.4.3. Revenue (US$ Mn) Comparison, By Application 

13. Global Antibodies Market Competition Landscape and Company Profile
13.1. Company Share Analysis By Region
13.2. Abcam Plc
       13.2.1. Company Overview
       13.2.2. Antibodies Market Product Type list
       13.2.3. Antibodies Market Product Type Sales Data and Key Financials
       13.2.4. Key Developments
       13.2.5. SWOT Analysis
13.3.A.M.S. Biotechnology (Europe) Limited
       13.3.1. Company Overview
       13.3.2. Antibodies Market Product Type list
       13.3.3. Antibodies Market Product Type Sales Data and Key Financials
       13.3.4. Key Developments
       13.3.5. SWOT Analysis
13.4. Bio-Rad Laboratories, Inc
       13.4.1. Company Overview
       13.4.2. Antibodies Market Product Type list
       13.4.3. Antibodies Market Product Type Sales Data and Key Financials
       13.4.4. Key Developments
       13.4.5. SWOT Analysis
13.5. Cell Signaling Technology
       13.5.1. Company Overview
       13.5.2. Antibodies Market Product Type list
       13.5.3. Antibodies Market Product Type Sales Data and Key Financials
       13.5.4. Key Developments
       13.5.5. SWOT Analysis
13.6. Sigma Aldrich Corporation
       13.6.1. Company Overview
       13.6.2. Antibodies Market Product Type list
       13.6.3. Antibodies Market Product Type Sales Data and Key Financials
       13.6.4. Key Developments
       13.6.5. SWOT Analysis
13.7.Crown Bioscience, Inc
       13.7.1. Company Overview
       13.7.2. Antibodies Market Product Type list
       13.7.3. Antibodies Market Product Type Sales Data and Key Financials
       13.7.4. Key Developments
       13.7.5. SWOT Analysis
13.8. Thermo Fisher Scientific, Inc
       13.8.1. Company Overview
       13.8.2. Antibodies Market Product Type list
       13.8.3. Antibodies Market Product Type Sales Data and Key Financials
       13.8.4. Key Developments
       13.8.5. SWOT Analysis

14. Research Methodology

15. Secondary and Primary Sources

16. Assumptions and Acronyms

17. Disclaimer

TABLE 1 Global Antibodies Market Value (US$ Mn), 2012-2016
TABLE 2 Global Antibodies Market Value (US$ Mn), 2017-2022
TABLE 3 Global Antibodies Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Immune Checkpoint Antibodies Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Immune Checkpoint Antibodies Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Immune Checkpoint Antibodies Segment Market Share, By Region 2012-2016
TABLE 7 Global Immune Checkpoint Antibodies Segment Market Share, By Region 2017-2022
TABLE 8 Global Immune Checkpoint Antibodies Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Epitope Tag Antibodies Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Epitope Tag Antibodies Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Epitope Tag Antibodies Segment Market Share, By Region 2012-2016
TABLE 12 Global Epitope Tag Antibodies Segment Market Share, By Region 2017-2022
TABLE 13 Global Epitope Tag Antibodies Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Isotype Control Antibodies Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Isotype Control Antibodies Segment Value (US$ Mn), By Region 2017-2022
TABLE 16 Global Isotype Control Antibodies Segment Market Share, By Region 2012-2016
TABLE 17 Global Isotype Control Antibodies Segment Market Share, By Region 2017-2022
TABLE 18 Global Isotype Control Antibodies Segment Y-o-Y, By Region 2015-2022
TABLE 19 Global Primary Antibodies Segment Value (US$ Mn), By Region 2012-2016
TABLE 20 Global Primary Antibodies Segment Value (US$ Mn), By Region 2017-2022
TABLE 21 Global Primary Antibodies Segment Market Share, By Region 2012-2016
TABLE 22 Global Primary Antibodies Segment Market Share, By Region 2017-2022
TABLE 23 Global Primary Antibodies Segment Y-o-Y, By Region 2015-2022
TABLE 24 Global Assay Antibodies (includes secondary antibodies) Segment Value (US$ Mn), By Region 2012-2016
TABLE 25 Global Assay Antibodies (includes secondary antibodies) Segment Value (US$ Mn), By Region 2017-2022
TABLE 26 Global Assay Antibodies (includes secondary antibodies) Segment Market Share, By Region 2012-2016
TABLE 27 Global Assay Antibodies (includes secondary antibodies) Segment Market Share, By Region 2017-2022
TABLE 28 Global Assay Antibodies (includes secondary antibodies) Segment Y-o-Y, By Region 2015-2022
TABLE 29 Global Other  Segment Value (US$ Mn), By Region 2012-2016
TABLE 30 Global Other  Segment Value (US$ Mn), By Region 2017-2022
TABLE 31 Global Other  Segment Market Share, By Region 2012-2016
TABLE 32 Global Other  Segment Market Share, By Region 2017-2022
TABLE 33 Global Other  Segment Y-o-Y, By Region 2015-2022
TABLE 34 Global Biopharmaceutical Companies Segment Value (US$ Mn), By Region 2012-2016
TABLE 35 Global Biopharmaceutical Companies Segment Value (US$ Mn), By Region 2017-2022
TABLE 36 Global Biopharmaceutical Companies Segment Market Share, By Region 2012-2016
TABLE 37 Global Biopharmaceutical Companies Segment Market Share, By Region 2017-2022
TABLE 38 Global Biopharmaceutical Companies Segment Y-o-Y, By Region 2015-2022
TABLE 39 Global Contract Research Organizations (CROs) Segment Value (US$ Mn), By Region 2012-2016
TABLE 40 Global Contract Research Organizations (CROs) Segment Value (US$ Mn), By Region 2017-2022
TABLE 41 Global Contract Research Organizations (CROs) Segment Market Share, By Region 2012-2016
TABLE 42 Global Contract Research Organizations (CROs) Segment Market Share, By Region 2017-2022
TABLE 43 Global Contract Research Organizations (CROs) Segment Y-o-Y, By Region 2015-2022
TABLE 44 Global Academic & Research Institutes Segment Value (US$ Mn), By Region 2012-2016
TABLE 45 Global Academic & Research Institutes Segment Value (US$ Mn), By Region 2017-2022
TABLE 46 Global Academic & Research Institutes Segment Market Share, By Region 2012-2016
TABLE 47 Global Academic & Research Institutes Segment Market Share, By Region 2017-2022
TABLE 48 Global Academic & Research Institutes Segment Y-o-Y, By Region 2015-2022
TABLE 49 Global Forensic Science Laboratories Segment Value (US$ Mn), By Region 2012-2016
TABLE 50 Global Forensic Science Laboratories Segment Value (US$ Mn), By Region 2017-2022
TABLE 51 Global Forensic Science Laboratories Segment Market Share, By Region 2012-2016
TABLE 52 Global Forensic Science Laboratories Segment Market Share, By Region 2017-2022
TABLE 53 Global Forensic Science Laboratories Segment Y-o-Y, By Region 2015-2022
TABLE 54 Global Food & Beverage Companies Segment Value (US$ Mn), By Region 2012-2016
TABLE 55 Global Food & Beverage Companies Segment Value (US$ Mn), By Region 2017-2022
TABLE 56 Global Food & Beverage Companies Segment Market Share, By Region 2012-2016
TABLE 57 Global Food & Beverage Companies Segment Market Share, By Region 2017-2022
TABLE 58 Global Food & Beverage Companies Segment Y-o-Y, By Region 2015-2022
TABLE 59 Global Diagnostic Centers Segment Value (US$ Mn), By Region 2012-2016
TABLE 60 Global Diagnostic Centers Segment Value (US$ Mn), By Region 2017-2022
TABLE 61 Global Diagnostic Centers Segment Market Share, By Region 2012-2016
TABLE 62 Global Diagnostic Centers Segment Market Share, By Region 2017-2022
TABLE 63 Global Diagnostic Centers Segment Y-o-Y, By Region 2015-2022
TABLE 64 Global Others Segment Value (US$ Mn), By Region 2012-2016
TABLE 65 Global Others Segment Value (US$ Mn), By Region 2017-2022
TABLE 66 Global Others Segment Market Share, By Region 2012-2016
TABLE 67 Global Others Segment Market Share, By Region 2017-2022
TABLE 68 Global Others Segment Y-o-Y, By Region 2015-2022
TABLE 69 Global Drug Discovery & Development Segment Value (US$ Mn), By Region 2012-2016
TABLE 70 Global Drug Discovery & Development Segment Value (US$ Mn), By Region 2017-2022
TABLE 71 Global Drug Discovery & Development Segment Market Share, By Region 2012-2016
TABLE 72 Global Drug Discovery & Development Segment Market Share, By Region 2017-2022
TABLE 73 Global Drug Discovery & Development Segment Y-o-Y, By Region 2015-2022
TABLE 74 Global Basic Research Segment Value (US$ Mn), By Region 2012-2016
TABLE 75 Global Basic Research Segment Value (US$ Mn), By Region 2017-2022
TABLE 76 Global Basic Research Segment Market Share, By Region 2012-2016
TABLE 77 Global Basic Research Segment Market Share, By Region 2017-2022
TABLE 78 Global Basic Research Segment Y-o-Y, By Region 2015-2022
TABLE 79 Global Toxicity Screening Segment Value (US$ Mn), By Region 2012-2016
TABLE 80 Global Toxicity Screening Segment Value (US$ Mn), By Region 2017-2022
TABLE 81 Global Toxicity Screening Segment Market Share, By Region 2012-2016
TABLE 82 Global Toxicity Screening Segment Market Share, By Region 2017-2022
TABLE 83 Global Toxicity Screening Segment Y-o-Y, By Region 2015-2022
TABLE 84 Global Biopharmaceutical Production Segment Value (US$ Mn), By Region 2012-2016
TABLE 85 Global Biopharmaceutical Production Segment Value (US$ Mn), By Region 2017-2022
TABLE 86 Global Biopharmaceutical Production Segment Market Share, By Region 2012-2016
TABLE 87 Global Biopharmaceutical Production Segment Market Share, By Region 2017-2022
TABLE 88 Global Biopharmaceutical Production Segment Y-o-Y, By Region 2015-2022
TABLE 89 Global Drug Screening Segment Value (US$ Mn), By Region 2012-2016
TABLE 90 Global Drug Screening Segment Value (US$ Mn), By Region 2017-2022
TABLE 91 Global Drug Screening Segment Market Share, By Region 2012-2016
TABLE 92 Global Drug Screening Segment Market Share, By Region 2017-2022
TABLE 93 Global Drug Screening Segment Y-o-Y, By Region 2015-2022
TABLE 94 Global Tissue Engineering Segment Value (US$ Mn), By Region 2012-2016
TABLE 95 Global Tissue Engineering Segment Value (US$ Mn), By Region 2017-2022
TABLE 96 Global Tissue Engineering Segment Market Share, By Region 2012-2016
TABLE 97 Global Tissue Engineering Segment Market Share, By Region 2017-2022
TABLE 98 Global Tissue Engineering Segment Y-o-Y, By Region 2015-2022
TABLE 99 Global Forensic Testing Segment Value (US$ Mn), By Region 2012-2016
TABLE 100 Global Forensic Testing Segment Value (US$ Mn), By Region 2017-2022
TABLE 101 Global Forensic Testing Segment Market Share, By Region 2012-2016
TABLE 102 Global Forensic Testing Segment Market Share, By Region 2017-2022
TABLE 103 Global Forensic Testing Segment Y-o-Y, By Region 2015-2022
TABLE 104 North America Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 105 North America Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 106 North America Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 107 North America Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 108 North America Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 109 North America Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 110 Latin America Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 111 Latin America Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 112 Latin America Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 113 Latin America Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 114 Latin America Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 115 Latin America Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 116 Europe Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 117 Europe Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 118 Europe Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 119 Europe Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 120 Europe Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 121 Europe Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 122 Japan Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 123 Japan Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 124 Japan Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 125 Japan Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 126 Japan Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 127 Japan Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 128 APEJ Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 129 APEJ Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 130 APEJ Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 131 APEJ Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 132 APEJ Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 133 APEJ Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 134 MEA Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 135 MEA Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 136 MEA Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 137 MEA Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 138 MEA Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 139 MEA Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 140 US Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 141 US Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 142 US Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 143 US Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 144 US Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 145 US Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 146 Canada Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 147 Canada Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 148 Canada Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 149 Canada Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 150 Canada Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 151 Canada Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 152 Brazil Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 153 Brazil Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 154 Brazil Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 155 Brazil Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 156 Brazil Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 157 Brazil Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 158 Mexico Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 159 Mexico Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 160 Mexico Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 161 Mexico Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 162 Mexico Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 163 Mexico Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 164 Argentina Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 165 Argentina Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 166 Argentina Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 167 Argentina Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 168 Argentina Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 169 Argentina Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 170 Germany Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 171 Germany Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 172 Germany Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 173 Germany Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 174 Germany Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 175 Germany Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 176 UK Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 177 UK Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 178 UK Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 179 UK Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 180 UK Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 181 UK Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 182 France Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 183 France Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 184 France Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 185 France Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 186 France Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 187 France Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 188 Spain Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 189 Spain Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 190 Spain Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 191 Spain Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 192 Spain Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 193 Spain Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 194 Italy Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 195 Italy Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 196 Italy Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 197 Italy Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 198 Italy Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 199 Italy Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 200 Nordic Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 201 Nordic Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 202 Nordic Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 203 Nordic Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 204 Nordic Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 205 Nordic Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 206 Japan  Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 207 Japan  Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 208 Japan  Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 209 Japan  Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 210 Japan  Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 211 Japan  Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 212 China Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 213 China Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 214 China Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 215 China Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 216 China Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 217 China Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 218 India Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 219 India Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 220 India Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 221 India Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 222 India Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 223 India Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 224 Malaysia Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 225 Malaysia Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 226 Malaysia Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 227 Malaysia Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 228 Malaysia Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 229 Malaysia Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 230 Thailand Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 231 Thailand Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 232 Thailand Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 233 Thailand Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 234 Thailand Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 235 Thailand Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 236 Singapore Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 237 Singapore Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 238 Singapore Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 239 Singapore Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 240 Singapore Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 241 Singapore Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 242 Australia Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 243 Australia Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 244 Australia Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 245 Australia Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 246 Australia Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 247 Australia Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 248 GCC Countries Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 249 GCC Countries Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 250 GCC Countries Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 251 GCC Countries Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 252 GCC Countries Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 253 GCC Countries Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 254 South Africa Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 255 South Africa Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 256 South Africa Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 257 South Africa Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 258 South Africa Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 259 South Africa Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 260 Nigeria Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 261 Nigeria Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 262 Nigeria Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 263 Nigeria Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 264 Nigeria Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 265 Nigeria Antibodies Market Value (US$ Mn), By Application 2017-2022
TABLE 266 Israel Antibodies Market Value (US$ Mn), By Product Type 2012-2016
TABLE 267 Israel Antibodies Market Value (US$ Mn), By Product Type 2017-2022
TABLE 268 Israel Antibodies Market Value (US$ Mn), By End User 2012-2016
TABLE 269 Israel Antibodies Market Value (US$ Mn), By End User 2017-2022
TABLE 270 Israel Antibodies Market Value (US$ Mn), By Application 2012-2016
TABLE 271 Israel Antibodies Market Value (US$ Mn), By Application 2017-2022

FIG. 1 Global Antibodies Market Value (US$ Mn), 2012-2016
FIG. 2 Global Antibodies Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Antibodies Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Immune Checkpoint Antibodies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Immune Checkpoint Antibodies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Immune Checkpoint Antibodies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Epitope Tag Antibodies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Epitope Tag Antibodies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Epitope Tag Antibodies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Isotype Control Antibodies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Isotype Control Antibodies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Isotype Control Antibodies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Primary Antibodies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Primary Antibodies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Primary Antibodies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 16 Global Assay Antibodies (includes secondary antibodies) Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 17 Global Assay Antibodies (includes secondary antibodies) Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 18 Global Assay Antibodies (includes secondary antibodies) Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 19 Global Other  Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 20 Global Other  Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 21 Global Other  Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 22 Global Biopharmaceutical Companies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 23 Global Biopharmaceutical Companies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 24 Global Biopharmaceutical Companies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 25 Global Contract Research Organizations (CROs) Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 26 Global Contract Research Organizations (CROs) Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 27 Global Contract Research Organizations (CROs) Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 28 Global Academic & Research Institutes Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 29 Global Academic & Research Institutes Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 30 Global Academic & Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 31 Global Forensic Science Laboratories Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 32 Global Forensic Science Laboratories Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 33 Global Forensic Science Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 34 Global Food & Beverage Companies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 35 Global Food & Beverage Companies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 36 Global Food & Beverage Companies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 37 Global Diagnostic Centers Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 38 Global Diagnostic Centers Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 39 Global Diagnostic Centers Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 40 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 41 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 42 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 43 Global Drug Discovery & Development Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 44 Global Drug Discovery & Development Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 45 Global Drug Discovery & Development Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 46 Global Basic Research Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 47 Global Basic Research Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 48 Global Basic Research Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 49 Global Toxicity Screening Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 50 Global Toxicity Screening Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 51 Global Toxicity Screening Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 52 Global Biopharmaceutical Production Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 53 Global Biopharmaceutical Production Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 54 Global Biopharmaceutical Production Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 55 Global Drug Screening Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 56 Global Drug Screening Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 57 Global Drug Screening Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 58 Global Tissue Engineering Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 59 Global Tissue Engineering Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 60 Global Tissue Engineering Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 61 Global Forensic Testing Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 62 Global Forensic Testing Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 63 Global Forensic Testing Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 64 North America Antibodies Market Value (US$ Mn), By Product Type 2012-2016
FIG. 65 North America Antibodies Market Value (US$ Mn), By Product Type 2017-2022
FIG. 66 North America Antibodies Market Value (US$ Mn), By End User 2012-2016
FIG. 67 North America Antibodies Market Value (US$ Mn), By End User 2017-2022
FIG. 68 North America Antibodies Market Value (US$ Mn), By Application 2012-2016
FIG. 69 North America Antibodies Market Value (US$ Mn), By Application 2017-2022
FIG. 70 Latin America Antibodies Market Value (US$ Mn), By Product Type 2012-2016
FIG. 71 Latin America Antibodies Market Value (US$ Mn), By Product Type 2017-2022
FIG. 72 Latin America Antibodies Market Value (US$ Mn), By End User 2012-2016
FIG. 73 Latin America Antibodies Market Value (US$ Mn), By End User 2017-2022
FIG. 74 Latin America Antibodies Market Value (US$ Mn), By Application 2012-2016
FIG. 75 Latin America Antibodies Market Value (US$ Mn), By Application 2017-2022
FIG. 76 Europe Antibodies Market Value (US$ Mn), By Product Type 2012-2016
FIG. 77 Europe Antibodies Market Value (US$ Mn), By Product Type 2017-2022
FIG. 78 Europe Antibodies Market Value (US$ Mn), By End User 2012-2016
FIG. 79 Europe Antibodies Market Value (US$ Mn), By End User 2017-2022
FIG. 80 Europe Antibodies Market Value (US$ Mn), By Application 2012-2016
FIG. 81 Europe Antibodies Market Value (US$ Mn), By Application 2017-2022
FIG. 82 Japan Antibodies Market Value (US$ Mn), By Product Type 2012-2016
FIG. 83 Japan Antibodies Market Value (US$ Mn), By Product Type 2017-2022
FIG. 84 Japan Antibodies Market Value (US$ Mn), By End User 2012-2016
FIG. 85 Japan Antibodies Market Value (US$ Mn), By End User 2017-2022
FIG. 86 Japan Antibodies Market Value (US$ Mn), By Application 2012-2016
FIG. 87 Japan Antibodies Market Value (US$ Mn), By Application 2017-2022
FIG. 88 APEJ Antibodies Market Value (US$ Mn), By Product Type 2012-2016
FIG. 89 APEJ Antibodies Market Value (US$ Mn), By Product Type 2017-2022
FIG. 90 APEJ Antibodies Market Value (US$ Mn), By End User 2012-2016
FIG. 91 APEJ Antibodies Market Value (US$ Mn), By End User 2017-2022
FIG. 92 APEJ Antibodies Market Value (US$ Mn), By Application 2012-2016
FIG. 93 APEJ Antibodies Market Value (US$ Mn), By Application 2017-2022
FIG. 94 MEA Antibodies Market Value (US$ Mn), By Product Type 2012-2016
FIG. 95 MEA Antibodies Market Value (US$ Mn), By Product Type 2017-2022
FIG. 96 MEA Antibodies Market Value (US$ Mn), By End User 2012-2016
FIG. 97 MEA Antibodies Market Value (US$ Mn), By End User 2017-2022
FIG. 98 MEA Antibodies Market Value (US$ Mn), By Application 2012-2016
FIG. 99 MEA Antibodies Market Value (US$ Mn), By Application 2017-2022

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development